Poly (D,L-lactic acid) (PLA) and poly (D,L-lactic-co-glycolic acid)(PLGA) biodegradable polymers provide better control over the release kinetics of final drug products. This improvement in control has been leveraged in a variety of different applications.
Additionally, nano- and microsphere formulations based on PLGA polymers are studied intensively for the injectable delivery of peptides, therapeutic proteins, hormones and antibiotics.
Our portfolio contains PLA and PLGA polymers, with varying polymer content and characteristics applicable for fine-tuning of sustained release of small molecule and selected peptide injectables.
Benefits of our PLA & PLGA polymer portfolio:
For more information about our offering of PLA/PLGA polymers, please see our flyer in the related resources section above.
EXPANSORB is a registered trademark of Groupe PCAS, Longjumeau, France.